Elizabeth Parrish CEO is a humanitarian, entrepreneur, innovator, and a leading voice for genetic cures. As a strong proponent of progress and education for the advancement of regenerative medicine modalities, she serves as a motivational speaker to the public at large for the life sciences. She is actively involved in international educational media outreach and sits on the board of the International Longevity Alliance (ILA). She is an affiliated member of the Complex Biological Systems Alliance (CBSA), which is a unique platform for Mensa based, highly gifted persons who advance scientific discourse and discovery.
The mission of the CBSA is to further scientific understanding of biological complexity and the nature and origins of human disease. She is the founder of BioTrove Investments LLC and the BioTrove Podcasts which is committed to offering a meaningful way for people to learn about and fund research in regenerative medicine. She is also the Secretary of The American Longevity Alliance (ALA) a 501(c)(3) nonprofit trade association that brings together individuals, companies, and organizations who work in advancing the emerging field of cellular & regenerative medicine.
Dr. Williams CMO is a radiologist with a passion for gene and cellular therapies that can be administered under image guidance. He also has an interest in image guided cancer therapies. He did research for several years with adenoviral vector technology for the treatment of cancer. He has spent the last five years involved in research using AAV technology. Dr. Williams obtained his medical degree from Louisiana State University and completed an internship in Internal Medicine followed by a residency in Radiology at The University Of South Alabama. In residency, he was selected for the RSNA Research Fellow award. He is board certified by The American Board of Radiology with additional training in image guided cancer and spine procedures. His research interest is in gene therapy and reprogramming of stem cells. He also has research interest in the use of CT and MRI guidance for minimally invasive procedures related to the spine and treatment of cancer.
Avi Roy COO is the President of the Biogerontology Research Foundation (BGRF), a UK-based charity founded to support ageing research and address the challenges of a rapidly ageing population. Avi is an Oxford based biomedical scientist, with degrees in biomedical science and computer science.
His PhD research involved the rejuvenation of human skin using small molecules, and identifying accurate biomarkers of aging. Avi rejuvenated the skin cells taken from 80 year old patients by transplanting the mitochondria taken from 16 year old skin cells. Using transcriptomics, proteomics and computational biology Avi identified the pathways involved in the rejuvenation of skin, and ever since has been screening small molecules to replicate the regenerative process. His research has resulted in an advanced protocol for screening drugs that have geroprotective properties, which has identified twelve novel geroprotective drugs.
Over the past eight years Oxford has been Avi’s home where he has headed the Oxford University Scientific Society, the world’s oldest student scientific organization. He also co-founded the Oxford Transhumanism and Emerging Technology Society, and the Oxford University Synthetic Biology Society. He is always involved in public dissemination of science and has organised over 370 talks, chaired 8 conferences and hosted 28 nobel prize winners. Recently, Avi has launched the Big Data Science in Medicine Conference series, the first conference series of its kind in Europe; and the Longevity Reporter, which has rapidly become the premier source for news about health and longevity.
After years of success in the entertainment industry appearing in films, on television, and in mini-series, Ms. Blackburn shifted her focus and began to build her health and fitness credentials by becoming the Founding Editor of Ms. Fitness Magazine in 1993, and the Founder of FITCAMPS (www.fitcamp.com), wellness retreats for adults, in 1994. From 2007 to December 2009, Ms. Blackburn was responsible for finding the money for the message of bringing Telomere Biology into the mainstream when she convinced the man who would later fund found TA Sciences to attend a conference in Palm Springs, CA. At that conference stem cell and telomere specialists Dr. Jerry Shea and Dr. Woody Wright discussed their work in the field. Subsequent to that meeting TA Sciences was born and TA-65 developed.
Logically, Blackburn was brought on board as Marketing Director for TA Sciences, Inc. She successfully created and implemented the first TA Think Tank conference which took place in Palm Springs, California in 2007, and which welcomed leaders in the fields of stem cell technology, telomerase research, and related fields. Ms. Blackburn developed and is co-author of The Immortality Edge, a prescriptive outlining how to stay vital and energetic for decades longer than formerly believed possible.
She has utilized her background as a performer on stage, movie screen and TV to add some sizzle to her current role as the go-to gal for those seeking the latest and greatest information in the world of 100 is the New 50! of which she is a pioneer.
Ms. Blackburn produced the inaugural T.A. Sciences “Telomere Talks,” live event/webinars which have been seen by thousands of people all over the globe. Ms. Blackburn also co-chaired the 2009 Manhattan Beach Project—Longevity Summit (www.manhattanbeachproject.com). (Subsequent to that she became a Co-Founder of Age Reversal, Inc.) In 2009, Ms. Blackburn co-founded the Telonauts Club (www.telonauts.com) for those who wish to connect with others and network about possibilities for extending lifespan.
Having successfully launched TA-65 Blackburn turned her energies to the biotech world and has worked as a consultant to Immune Therapeutics, a company deeply entrenched in the world of immunology with its product Low Dose Natlrexone, LDN, which is currently undergoing clinical trials in Africa as a solution to HIV/AIDS.
lackburn now turns her attention to the most cutting edge therapy to emerge in the world of biotech, medicine and longevity: gene therapy with BioViva Sciences, Inc.
Mark Rosenberg, MD, FACEP, is board certified from the American Academy of Anti-aging Medicine. He has worked in both oncology and with the internal mechanisms of cellular aging. He serves at both medical director and medical advisor to the top diagnostic and therapeutic companies.
In addition to being an astute clinician, Dr. Rosenberg is a research scientist, and is actively involved in the development of drugs and techniques to combat cancer, obesity, and age-related diseases.
He holds a patent-pending on a novel drug for obesity, as well as a patent-pending for a cancer "cocktail," designed to specifically attack resistant cancer cells.
David A. Kekich is a recognized authority on longevity science. In 1999, he founded “Maximum Life Foundation”, a 501(c)(3) not-for-profit corporation dedicated to reversing human aging and aging related diseases. Since then, the Foundation, in concert with many of the world’s leading researchers, has developed a scientific road map to transform the elderly to biological youth.
David first became intrigued with extreme life extension in 1977 after founding the country’s largest life insurance master general agency, which raised $3.1 billion of premium income for First Executive Corp. This was where he was widely exposed to the realities and horrors of death from aging.
Currently, he also serves as CEO of SciCog Systems, Inc. and Age Reversal, Inc. He serves as a Board Member of the American Aging Association, Life Extension Buyers’ Club and Alcor Life Extension Foundation Patient Care Trust Fund. He authored “Smart, Strong and Sexy at 100?: New skin. New hair. New you… 7 simple steps to thrive at 100… and beyond,” a how-to book for extreme life extension.
He starred in two life extension documentaries and was featured in three others. Mr. Kekich is a popular lecturer and spoke to thousands of people on the topic. He has appeared on numerous television and radio shows and on many webinars. He was also featured in newspaper and magazine articles and publishes a widely read newsletter, Longevity News Alert.
Dr Slajer is an expert in bioreactor design and operation. She earned a DPhil in Engineering Science from the University of Oxford, where her research focused on designing a bioreactor to grow microalgae and on scaling-up algae growth to produce algal biodiesel on an industrial scale. She also earned summa cum laude during her Master’s degree in Environmental Engineering from the University of Oklahoma. Moreover, Dr Slajer has a broad scientific background and holds magna cum laude Bachelor’s degrees in Biology, Chemistry, and Mathematics.
Dr Slajer is passionate about promoting cutting-edge scientific research to a wider audience. To accomplish this, she served repeatedly on the Oxford University Scientific Society committee. As society President, she arranged and hosted 20 talks by prominent scientists in all areas of research. This included the 2012 debate between Dr Aubrey de Grey, Prof Colin Blakemore, and Prof Sir Richard Peto, which was titled The Debate of the Ages: This House Wants to Defeat Aging Entirely. In addition, she was part of the committee behind the University of Oxford’s 2010 International Women’s Leadership Symposium on Energy, Climate Change & Social Entrepreneurship.
Robert graduated with a First Class Honours in Biochemistry from the University of London, conducting his final research project in molecular biology within the Advanced Gene and Cell Therapy Laboratory at Royal Holloway University. A passionate biogerontology and longevity advocate, he is currently senior editor at The Longevity Reporter, the premier source of longevity, healthcare and aging related news. He has also interned and consulted at the UK based think tank, The Biogerontology Research Foundation.
Robert possesses an additional degree in BA Film Production, and is focused on combining scientific rigour within a multidisciplinary approach to solving the ethical and practical challenges posed by aging and age-related disease.